Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Disease and Biomarker Profiling of Chinese Lupus Nephritis

NCT06210464 is registered in ClinicalTrials.gov with Nan Shen as lead sponsor.

NCT NCT06210464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06210464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Disease and Biomarker Profiling of Chinese Lupus Nephritis
Lead sponsor
Nan Shen
Phase
Observational
Overall status
Unknown status
Start date
February 14, 2024
Completion date
March 1, 2025
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

characterize the molecular profile of lupus nephritis(ln) patients to understand themechanism(s)contributing to patient responsiveness to soc, integrated analysis of ln patient molecular profiling and clinical annotations to understand lndisease heterogeneity for disease endotype, validate the association of the candidate biomarker panel proposed in table 3-1 with ln diseasemonitoring